Search results
Author(s):
Veraprapas Kittipibul
,
Marat Fudim
Added:
3 months ago
PCI in Women
Author(s):
Mirvat Alasnag
,
Valeria Paradies
,
Nicola Ryan
,
et al
Added:
4 months ago
Article
Author(s):
Howard C Herrmann
Added:
3 years ago
Mitral regurgitation (MR) is most often caused by degenerative disease of the leaflets or develops functionally as a consequence of left ventricular disease (see Figure 1). Patients with severe MR have dyspnea on exertion, fatigue, and, when associated with left ventricular dysfunction or pulmonary hypertension, reduced survival.1 Therefore, surgery to repair or replace the mitral valve is…
View more
Author(s):
Ankit Agrawal
,
Toshiaki Isogai
,
Shashank Shekhar
,
et al
Added:
12 months ago
Author(s):
Duraisamy Balaguru
,
Rajiv Verma
Added:
3 years ago
Surgical repair has been the cornerstone of treatment for congenital heart diseases (CHD). However, cardiac catheterization has evolved from being a diagnostic modality to a therapeutic one in the past four decades. Application of catheter-based therapy has become the standard of care for some congenital heart defects, thus obviating surgery. This review will discuss congenital heart defects that…
View more
Author(s):
Soraya M Samii
,
Javier E Banchs
Added:
3 years ago
Abstract
The concept of using an implantable device to manage arrhythmias and heart failure started over 50 years ago. Since then, we have seen these devices improve patient outcomes from bradyarrhythmias, atrial fibrillation, ventricular arrhythmias, and heart failure. These devices are now standard of care in the management of patients and include pacemakers, implantable cardioverter…
View more
Author(s):
Horst Sievert
Added:
6 years ago
In this video, Dr Horst Sievert discusses the trial evidence to support the use of PFO closure devices.
View more
Author(s):
Rachel Koch Warnock
,
Roshan D Modi
,
Stacy B Westerman
Added:
6 months ago
Transseptal Access After Interatrial Shunt Devices: Try Everything Once and Great Things Twice
Author(s):
Molly Silkowski
,
Nicholas Amoroso
Added:
3 months ago
Article
Author(s):
Rhian E Davies
,
J Dawn Abbott
Added:
3 years ago
Percutaneous Coronary Intervention for Clinical Syndromes
Stable Angina
The primary benefit of percutaneous coronary intervention (PCI) over medical therapy in patients with stable angina is the improved quality of life. The PCI in stable angina (ORBITA) trial was the first sham-controlled trial of PCI where 200 medically optimized patients with single vessel disease were randomized to PCI or…
View more